Corcept Therapeutics Incorporat (CORT) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 98.3%
EBITDA Margin: -29.7%
Op. Margin: -30.1%
Net Margin: -19.3%

Op. margin of -30.1% is down 32.3% YoY — costs are rising relative to revenue. Net margin at -19.3% and gross margin of 98.3% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit